Skip to content

Assessing the DSR Ankle

Assessment of a Microprocessor Ankle for Low Mobility Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05955378
Enrollment
5
Registered
2023-07-21
Start date
2023-08-22
Completion date
2024-12-19
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Limb Deficiencies

Keywords

Amputation, Transtibial, K2, Limited Community Ambulator

Brief summary

This research is being done to conduct a preliminary investigation into a new prosthetic microprocessor controlled (MPC) ankle, called the Damping, Stiffness, and Repositioning (DSR) ankle. The DSR ankle is a new design to support a person while they walk on both even and uneven ground, as well as with bending the ankle for safe foot clearance while a person takes a step. In particular, in this study we are interested in seeing how this type of new device may benefit people who are rated as a K2-level ambulator.

Detailed description

Synchro Motion, LLC developed a novel MPC ankle. Because of its unique actuation scheme, the prosthesis can behave as: (1) a lockable conformal damper, (2) a variable set-point spring, and (3) an actively repositionable joint. The investigators therefore refer to the device as the damping, stiffness, and repositioning (DSR) ankle. The DSR ankle is small, lightweight, quiet, and runs for multiple days on a single charge. No other commercially available prosthesis combines this set of features. It will be shown in preliminary work that the features of the DSR ankle can increase toe clearance in swing, reduce the time-to-foot-flat after heel strike, and improve weight bearing symmetry when standing on slopes for K3 Individuals with Lower Limb Amputation (ILLAs). These biomechanical functions have all been linked to improved safety and stability, which leads the investigators to hypothesize that the DSR ankle may provide benefits to K2 ILLAs as well. The main purpose of this research is to determine the ways in which the DSR ankle may be adapted to provide benefits specifically to ILLAs who use their prosthesis at the K2 level. For purposes of the Phase I work, the development and assessment will be performed exclusively with K2 ILLAs in order to provide an opportunity to implement any necessary refinements to the DSR ankle to ensure optimal K2 performance. The remainder of the research is to quantify the effectiveness of the DSR ankle as compared to a predicate non-MPC ankle in improving performance for K2 ILLAs.

Interventions

DEVICEDSR Ankle

This is the experimental ankle component used in the overall prosthetic intervention.

DEVICEPredicate Ankle

This is the participant's prescribed ankle/foot complex used in the overall prosthetic intervention.

Sponsors

Shirley Ryan AbilityLab
CollaboratorOTHER
Synchro Motion LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

AB/BA

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

1. Adults aged 18-89 years 2. Patients who have a unilateral transtibial amputation who are able to use a prosthesis and who currently use a passive, non-MPC prosthesis 3. K2 level ambulators

Exclusion criteria

1. Pregnant women 2. Children (\<18 years old) 3. Prisoners or institutionalized individuals 4. Individuals who have the inability to give informed consent 5. Participants unable to walk for 2 minutes without an assistive device 6. Participants with complicating health conditions that interfere with the study 7. Inability to read and understand the English language. As this is a pilot study with a small sample size, it is prohibitive to translate Study documents to other languages as recruitment will be from a sample of convenience.

Design outcomes

Primary

MeasureTime frameDescription
Minimum Foot Clearanceafter up to 3 weeks of trainingMinimum foot clearance is the shortest distance between the foot and the ground during swing, and it occurs approximately halfway through the swing phase of gait.
Time to Foot Flatafter up to 3 weeks of trainingTime to foot flat is the duration of time between initial contact at heel strike and the full contact of the sole of the foot on the ground in stance.

Secondary

MeasureTime frameDescription
Orthotics Prosthetics User Survey (OPUS) Device Satisfactionafter up to 3 weeks of trainingThe OPUS is a self-report questionnaire consisting of 5 modules. It can be used for prosthetic and orthotic programs for quality assessment, to maintain awareness of improvement in activities, to evaluate changes in patient's functional status and quality of life, and to assess satisfaction with devices and services. The Device Satisfaction module uses a 5-point Likert scale (1 to 5), with a total score range of 11 to 55. Higher values indicate higher levels of satisfaction.
10 Meter Walk Test (10 MWT)after up to 3 weeks of trainingThe 10 MWT assesses walking speed in meters per second over a distance of 10 meters.
Six Minute Walk Test (6 MWT)after up to 3 weeks of trainingThe 6 MWT assesses walking distance in meters over a period of 6 minutes.
Timed Up and Go (TUG)after up to 3 weeks of trainingThe TUG assesses mobility, balance, walking ability, and fall risk in older adults.

Countries

United States

Participant flow

Recruitment details

5 patients were enrolled between August 22, 2023 and November 19, 2024 at the Shirley Ryan AbilityLab in Chicago, IL.

Pre-assignment details

3 of 5 patients completed this cross-over study.

Participants by arm

ArmCount
Predicate Ankle, Then DSR Ankle
Participants first performed assessments with their predicate (daily use) prosthetic ankle. After a washout period of at least 2 weeks, they were trained and assessed with the DSR Ankle. The DSR Ankle is a novel microprocessor-controlled ankle prosthesis that is able to provide enhanced mobility and stability to individuals with lower limb amputation.
2
DSR Ankle, Then Predicate Ankle
Participants first performed assessments with the DSR Ankle. The DSR Ankle is a novel microprocessor-controlled ankle prosthesis that is able to provide enhanced mobility and stability to individuals with lower limb amputation. After a washout period of at least 2 weeks, they were trained and assessed with their predicate (daily use) prosthetic ankle.
1
Total3

Baseline characteristics

CharacteristicDSR Ankle, Then Predicate AnkleTotalPredicate Ankle, Then DSR Ankle
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants2 Participants2 Participants
Age, Categorical
Between 18 and 65 years
1 Participants1 Participants0 Participants
Age, Continuous59 years
STANDARD_DEVIATION 0
74.3 years
STANDARD_DEVIATION 13.4
82 years
STANDARD_DEVIATION 2.8
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
1 participants3 participants2 participants
Sex: Female, Male
Female
1 Participants2 Participants1 Participants
Sex: Female, Male
Male
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 5
other
Total, other adverse events
0 / 50 / 5
serious
Total, serious adverse events
0 / 50 / 5

Outcome results

Primary

Minimum Foot Clearance

Minimum foot clearance is the shortest distance between the foot and the ground during swing, and it occurs approximately halfway through the swing phase of gait.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR AnkleMinimum Foot Clearance4.07 centimetersStandard Deviation 0.96
Predicate AnkleMinimum Foot Clearance3.87 centimetersStandard Deviation 1.11
Primary

Time to Foot Flat

Time to foot flat is the duration of time between initial contact at heel strike and the full contact of the sole of the foot on the ground in stance.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR AnkleTime to Foot Flat0.31 secondsStandard Deviation 0.13
Predicate AnkleTime to Foot Flat0.27 secondsStandard Deviation 0.19
Secondary

10 Meter Walk Test (10 MWT)

The 10 MWT assesses walking speed in meters per second over a distance of 10 meters.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR Ankle10 Meter Walk Test (10 MWT)0.41 meters per secondStandard Deviation 0.28
Predicate Ankle10 Meter Walk Test (10 MWT)0.53 meters per secondStandard Deviation 0.29
Secondary

Orthotics Prosthetics User Survey (OPUS) Device Satisfaction

The OPUS is a self-report questionnaire consisting of 5 modules. It can be used for prosthetic and orthotic programs for quality assessment, to maintain awareness of improvement in activities, to evaluate changes in patient's functional status and quality of life, and to assess satisfaction with devices and services. The Device Satisfaction module uses a 5-point Likert scale (1 to 5), with a total score range of 11 to 55. Higher values indicate higher levels of satisfaction.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR AnkleOrthotics Prosthetics User Survey (OPUS) Device Satisfaction45 units on a scaleStandard Deviation 5.66
Predicate AnkleOrthotics Prosthetics User Survey (OPUS) Device Satisfaction44.5 units on a scaleStandard Deviation 3.54
Secondary

Six Minute Walk Test (6 MWT)

The 6 MWT assesses walking distance in meters over a period of 6 minutes.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR AnkleSix Minute Walk Test (6 MWT)145.1 metersStandard Deviation 121.48
Predicate AnkleSix Minute Walk Test (6 MWT)162.9 metersStandard Deviation 142.84
Secondary

Timed Up and Go (TUG)

The TUG assesses mobility, balance, walking ability, and fall risk in older adults.

Time frame: after up to 3 weeks of training

ArmMeasureValue (MEAN)Dispersion
DSR AnkleTimed Up and Go (TUG)42.17 secondsStandard Deviation 26.16
Predicate AnkleTimed Up and Go (TUG)23.13 secondsStandard Deviation 14.87

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026